You probably won’t make money by using pain control, but your calves will feel better, pair up faster and you’ll be doing ...

Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued ...

From stem cell research to spinal implants, here are three studies Becker's reported on since Jan. 15.

New blinded preliminary BRTX-100 data described this past Saturday at prestigious “2025 Winners in Industry Innovations in ...

A transradial approach for cerebral angiography was less effective than the transfemoral route in achieving an accurate diagnostic success rate.

VVeno Medical (NVNO) announced that interim two-year follow-up data on 34 subjects from the VenoValve U.S. pivotal trial will be presented ...

Range of motion was measured with passive straight leg raise and hip internal rotation. Visual analogue scales were completed for hamstring and gluteal pain and tightness at rest and during a running ...

Acupuncture has emerged as a promising treatment for primary osteoporosis (POP), according to a new meta-analysis involving ...

Outcome measures included number of missed training days due to pain and three visual analogue scale (VAS) items for pain during rest, activities of daily living and with running. Results 194 missed ...

Objective: This study aims to investigate the drainage effect and clinical outcomes of negative pressure chest drainage in patients after two-port thoracoscopic valve surgery, comparing the ...

H.C. Wainwright reiterated its Buy rating on OKYO Pharma Ltd. (NASDAQ: OKYO) with a price target of $7.00, representing significant upside potential from the current trading price of $1.10. According ...

a Likert-scale rating of pain at the end of the dosing interval; visual analogue scale (VAS) pain ratings over the 24 hours prior to each visit; and patient and investigator global ratings of pain.